default author photo

Vered Stearns

Cornell University - Weill Cornell Medicine

1300 York Avenue

New York, NY 10065

United States

SCHOLARLY PAPERS

1

DOWNLOADS

42

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Composite 18f-Fdg Pet/Ct and Her2 Tissue-Based Biomarker to Predict Response to Neoadjuvant Pertuzumab and Trastuzumab in Her2-Positive Breast Cancer (Tbcrc026)

Number of pages: 33 Posted: 27 Nov 2024
Cork University Hospital, affiliation not provided to SSRN, University of Alberta, Mayo Clinic, Mayo Clinic, Johns Hopkins University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Baylor College of Medicine, University of Washington, Indiana University - School of Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, Johns Hopkins University, affiliation not provided to SSRN, affiliation not provided to SSRN, Cornell University - Weill Cornell Medicine, Mayo Clinic and affiliation not provided to SSRN
Downloads 42 (1,170,409)

Abstract:

Loading...

18F-FDG PET/CT, HER2-Biomarkers, breast cancer, Neoadjuvant